admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

MIND CURE ENTERS INTO BINDING LETTER OF INTENT WITH LNG ENERGY...

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic...

Psyence Group Announces Closing of Second Tranche of Private Placement and...

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets...

Algernon Pharmaceuticals Receives U.S. FDA Orphan Drug Designation for Ifenprodil for...

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100

Vital 2023: Informational Session and Q&A

Psychedelic Health – New course launches to bridge the psychedelic education...

Vice – How to Microdose Drugs Based on What You’re Using

1...101102103...218 Page 102 of 218

EDITOR PICKS

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of...

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin